Cargando…
Cytomegalovirus Colitis during Dasatinib Treatment for Patients with Hematologic Malignancy: Case Series and Literature Review
Dasatinib, a tyrosine kinase inhibitor, is widely used for patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. Although the drug has a potent immunosuppressive effect, infectious complications during dasatinib treatment have been reported rarely....
Autores principales: | Choi, Jae-Ki, Cho, Sung-Yeon, Choi, Su-Mi, Kim, Gyo Hui, Lee, Sung-Eun, Lee, Seok, Kim, Dong-Wook, Lee, Dong-Gun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Infectious Diseases and Korean Society for Chemotherapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031599/ https://www.ncbi.nlm.nih.gov/pubmed/29968984 http://dx.doi.org/10.3947/ic.2018.50.2.153 |
Ejemplares similares
-
Proven Cytomegalovirus Colitis Associated with Dasatinib Administration in Two Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients
por: Kim, Jeong Min, et al.
Publicado: (2023) -
Risk factors and clinical outcomes of breakthrough yeast bloodstream infections in patients with hematological malignancies in the era of newer antifungal agents
por: Kim, Si-Hyun, et al.
Publicado: (2018) -
Diagnosis of cytomegalovirus pneumonia by quantitative polymerase chain reaction using bronchial washing fluid from patients with hematologic malignancies
por: Lee, Hwa Young, et al.
Publicado: (2017) -
Dasatinib-induced hemorrhagic colitis complicated with cytomegalovirus infection
por: Nakaya, Aya, et al.
Publicado: (2017) -
Stenotrophomonas maltophilia bloodstream infection in patients with hematologic malignancies: a retrospective study and in vitro activities of antimicrobial combinations
por: Cho, Sung-Yeon, et al.
Publicado: (2015)